Solid Biosciences LLC (SLDB) Stock Analysis

Solid Biosciences LLC (SLDB) is a publicly traded company in the HEALTHCARE sector. It trades at $6.58, carries a market capitalization of $707.85M. This page summarizes the public market data, fundamentals, and frequently asked questions for SLDB, with GNG Research's proprietary safety, quality, and valuation analysis available to members.

Sector: HEALTHCARE - BIOTECHNOLOGY

Exchange: NASDAQ

Key Metrics

Market Sentiment

Solid Biosciences LLC currently has a Bullish sentiment score of 0.24.

About Solid Biosciences LLC

Solid Biosciences Inc. is a leading life sciences company dedicated to developing innovative gene therapies for Duchenne muscular dystrophy (DMD), a debilitating genetic disorder predominantly impacting young boys. Based in Cambridge, Massachusetts, the company is focused on addressing significant unmet medical needs through its advanced pipeline aimed at restoring functional dystrophin. By prioritizing translational science and leveraging collaborations within the DMD community, Solid Biosci...

GNG Research Analysis

GNG Research scores Solid Biosciences LLC (SLDB) on three proprietary dimensions — a Safety score, a Quality score, and a Valuation score — alongside fair value estimates and buy-price targets for 5,000+ companies. These ratings are reserved for members. Read how the scores are calculated on our methodology page, or see GNG Research plans to unlock the full rating for SLDB.

Frequently Asked Questions

Does SLDB pay dividends?

Solid Biosciences LLC (SLDB) does not currently pay a regular dividend.

What is SLDB's market cap?

Solid Biosciences LLC (SLDB) has a market capitalization of $707.85M with a current stock price of $6.58.